Fig. 1
From: A proteomic classifier panel for early screening of colorectal cancer: a case control study
Study design. Flow chart showing the discovery and validation phases of this study. A Discovery cohort for quantitative proteomic analysis using DDA and DIA methods. B MRM targeted proteomic assay development. C Applying the MRM assay to an independent validation cohort of patients to classify CRC and APC patients from healthy controls. D Applying the MRM assay to a blinded validation cohort, in which the diagnosis was disclosed only after the test results were given